Paris, France and Camberley, UK - 3 June 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the launch of two new polymerase chain reaction (PCR) assays, expanding its genesig® COVID-19 and SNPsig® SARS-CoV-2 variant detection portfolios.

http://novacyt.com/wp-content/uploads/2021/06/Novacyt-Launch-of-two-new-PCR-COVID-19-assays-final.pdf

Attachments

  • Original document
  • Permalink

Disclaimer

Novacyt SA published this content on 03 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 June 2021 06:06:05 UTC.